difference between ozempic and tirzepatide Semaglutide key differences, weight loss results (2026) Mounjaro vs Ozempic (2026): Which

Tirzepatide (Zepbound 15 mg) The SURMOUNT-1 trial , which studied tirzepatide for weight loss, showed that patients taking 15 mg of tirzepatide weekly lost an average of 22.5% of their body weight over 72 weeks a significantly greater reduction compared to semaglutide

You should be aware of the following symptoms, and if you feel any of them, you should contact your doctor immediately: Both Ozempic and Mounjaro come with a "boxed warning" about the risk of thyroid cancer

GLP-1 response varies across patients: variants in GLP1R, GIPR (rs1800437), FTO, MC4R, and TCF7L2 are associated with measurably different response patterns to semaglutide and tirzepatide

Perfecto para aquellos que prefieren una alternativa verstil a las cpsulas o polvos